Problem Statement

Biocon's Gross and Operating Profit Margins for FY2023 Biocon has announced the following results for the fiscal year ending 31 March 2023: Revenue $4,000 Mn, Cost of Goods Sold $2,400 Mn, Operating Expenses $600 Mn, Interest Expenses $100 Mn. Corporate tax is 35%. Compute the gross profit margin and the operating profit margin.